Honeywell International’s AstraZeneca AZN Stock Holding History

Honeywell International’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-150,000	Closed	-$10.2M	–	165
2017 Q2	$10.2M	Sell	150,000 -82,500	-35%	-$5.39M	0.39%	99
2017 Q1	$14.5M	Buy	+232,500	New	+$13.5M	0.47%	84
2016 Q3	–	Sell	-420,750	Closed	-$25.4M	–	178
2016 Q2	$25.4M	Hold	420,750	–	–	0.65%	60
2016 Q1	$23.7M	Buy	+420,750	New	+$25.3M	0.6%	71
2013 Q4	–	Sell	-495,000	Closed	-$25.7M	–	169
2013 Q3	$25.7M	Buy	495,000 +50,000	+11%	+$2.51M	0.66%	53
2013 Q2	$21M	Buy	+445,000	New	+$22.7M	0.57%	66

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Honeywell International's AZN Position: Q3 2017 in Review

Honeywell International sold out of AstraZeneca (AZN) in Q3 2017, closing a stake of 150,000 shares — an estimated $10.2M sold.

Honeywell International first reported a position in AZN in Q2 2013 and held it in 6 quarters. The position peaked at $25.7M in Q3 2013. 455 funds tracked by Wall St. Rank hold AZN as of Q3 2017.

Honeywell International reported no remaining AstraZeneca position as of Q3 2017 after selling out during the quarter.
Honeywell International sold 150,000 AstraZeneca shares in Q3 2017, an estimated $10.2M.
Honeywell International first reported a position in AstraZeneca in Q2 2013 and held it in 6 quarters.
Honeywell International's AstraZeneca position peaked at $25.7M in Q3 2013.
455 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2017.

Based on Honeywell International's 13F filing for Q3 2017, filed 26 Oct 2017.